NBCC wins ₹20.92 cr orders; MAR’26 revenue ₹4,619 cr

What NBCC announced and why it matters

NBCC (India) Limited said it has secured two new work orders worth a combined ₹20.92 crore (excluding GST) in the ordinary course of business. The projects add to NBCC’s activity in healthcare-linked infrastructure, an area where the company and its subsidiaries have been visible through multiple recent order wins cited in market reports and filings. For investors tracking a PSU contractor, the key trigger is not only the size of an individual order but the consistency of inflows and the mix of clients across central PSUs and government-linked entities. The update also sits alongside financial datapoints shared for MAR ’26, where revenue and profit rose sharply year-on-year.

Two new work orders: scope, clients, and locations

According to the regulatory filing referenced in the report, the first work order is valued at about ₹8.48 crore. It has been awarded by the Chennai Port Authority for improvement works at the Medical and Surgical Blocks of the Chennai Port Authority Hospital in Chennai. The second work order is worth around ₹12.44 crore and comes from Power Grid Corporation of India Limited (PGCIL). That project involves construction of a 150-bedded Vishram Sadan at the Government General Hospital in Kurnool, Andhra Pradesh.

Both orders are described as being received in the ordinary course of business and the combined value is stated at approximately ₹20.92 crore, excluding GST. While the ticket size is small compared with NBCC’s larger redevelopment and institutional projects discussed elsewhere in the provided text, such healthcare-oriented jobs often strengthen credentials and relationships in a segment where repeat orders can follow.

MAR ’26 financial snapshot: revenue, profit, and growth indicators

The provided financial snapshot for MAR ’26 reports revenue of ₹4,619 crore, up 49.25%, and profit of ₹254 crore, up 28.54%. Alongside this, the revenue growth table shows 1-year (TTM) revenue growth of -2% and a 3-year CAGR of +16%. The profit growth table shows 1-year (TTM) profit growth of +39% and a 3-year CAGR of +33%.

These numbers, taken together, point to a quarter (MAR ’26) that is stronger year-on-year on headline revenue and profit, even as the TTM revenue growth figure shown is slightly negative. The divergence between a strong single-period growth rate and a softer TTM revenue growth number can matter for investors who focus on sustainability of execution and billing cycles.

Key numbers at a glance

NBCC share price returns: short-term moves and long-term run-up

The report also lists NBCC share price returns across time frames, showing positive performance over most periods, especially over longer horizons. Over one day, the stock is shown up 5.32%, and over one week up 6.74%. The one-year return is listed at 14.17%, while three-year and five-year returns are much higher at 324.75% and 446.87%, respectively.

Earlier disclosures highlighted: ₹289.39 crore orders (Dec 2025)

The provided text also references a separate regulatory disclosure dated Friday, December 12, 2025, where NBCC announced it had secured two major work contracts amounting to ₹289.39 crore. At 1:30 PM on that day, NBCC shares were trading at ₹108.71, up 0.37% versus the previous close. In the same snippet, the second contract is described as being awarded by SAIL Bokaro with a total value of ₹33.89 crore (excluding GST). These older disclosures are relevant because they show that the company’s order-flow news has been frequent, with varying ticket sizes and multiple PSU/government-linked counterparties.

Healthcare projects have featured prominently in recent order flow

Beyond NBCC’s own wins, the text repeatedly cites healthcare-related projects, including a mention that NBCC’s arm HSCC (India) Limited secured orders worth ₹1,322.48 crore. Another report segment says NBCC share price spiked after HSCC won contracts worth about ₹599.35 crore, including ₹259.35 crore for ‘Hinduhṛday Samrāṭ Bālāsāheb Ṭhākray Āplā Dawākhānā’ under Maharashtra’s National Health Mission and a ₹340 crore project for radiation oncology units in four districts: Jalna, Ratnagiri, Baramati and Dharashiv.

Separately, the text notes a market move on September 23 when shares rose as much as 2.5% after NBCC won an order worth ₹1,261 crore from the Ministry of Health and Family Welfare for establishment work of AIIMS in Darbhanga, Bihar. It also mentions that at 1.31 pm, shares were trading at ₹177.50 on the NSE. Together, these references position healthcare as a recurring theme in the company’s and its units’ project pipeline.

Other cited triggers: sales, bonus issue, and large pipeline items

The compilation also cites that NBCC announced, via two separate filings, sales of commercial spaces worth ₹2,251 crore. It further notes the board approved a bonus issue of one share for every two equity shares held, with a record date of October 7, and that the stock had jumped over 10% in anticipation before showing “tepid performance” due to profit booking.

On the pipeline side, the text mentions HSCC secured a work order worth ₹528.21 crore from the Directorate of Medical Education & Research, Haryana, for procuring biomedical equipment and hospital furniture for Pt. Deen Dayal Upadhyaya University of Health Sciences in Kutail, Karnal. It also references a much larger award of ₹15,000 crore from the Srinagar Development Authority for developing a satellite township spanning 406 acres at Rakh-e-Gund Akshah, Bemina, Srinagar (J&K).

Market impact: what investors are reacting to

Across the snippets, the stock’s price action is repeatedly linked to order wins and disclosures, including intraday surges such as 11% at ₹158 on the BSE in a separate instance, and an 8.4% move to ₹141 in another. There is also a reference to the stock touching a record high of ₹198.25 on July 9, 2024 and a 52-week low of ₹47.51 on August 22, 2023, as well as another 52-week high and low cited as ₹139.90 (28/08/2024) and ₹42.55 (28/11/2023). These data points underline that NBCC has been volatile while delivering strong multi-year returns, and that incremental contract wins tend to act as near-term triggers for momentum traders.

From a fundamentals lens, the MAR ’26 revenue and profit numbers provided, the profit growth metrics (TTM +39%, 3Y CAGR +33%), and the company’s own guidance cited in the text help explain why order flow matters. Management guidance in the provided content indicates a target of ₹13,000 crore revenue and 5.5% to 6% EBITDA margins for FY25, alongside order wins of ₹19,800 crore in Q1FY25 and projects awarded worth ₹3,700 crore during the quarter.

Conclusion

NBCC’s latest ₹20.92 crore (excluding GST) orders from Chennai Port Authority and PGCIL extend its participation in healthcare-related infrastructure and add to a broader stream of order-related triggers referenced across filings and reports. The MAR ’26 snapshot shows revenue of ₹4,619 crore and profit of ₹254 crore, while longer-term growth tables point to a mixed TTM revenue trend but stronger profit growth. Investors are likely to keep tracking new disclosures, especially given the company’s stated FY25 revenue and margin guidance and the recurring pattern of order-flow news influencing the stock.